Several VIC portfolio companies, as well as new technologies in our opportunity assessment pipeline, have the potential to mitigate current and future pandemics.

 

Developing innovative drugs that prevent brain damage following ischemic events such as cardiac arrest and stroke.

An opportunity for individuals to learn about the process of identifying and evaluating promising life science technologies.

 

 

SFC Fluidics’ mission is to eliminate the constant worry of diabetes through automation of multiple daily blood glucose tests and insulin injections.

 

Have an idea for a white paper, case study, interview or other type of content related to the topic of life science investing? Please let us know.